Mania and hypomania can look similar at first glance because both involve a clear shift in mood and energy. Patients may seem more activated, more confident, more talkative, more distractible, and less in need of sleep. The difference is not just intensity. It is what happens to functioning once the episode takes hold.

Hypomania is still a pathologic mood state, but it does not by itself cause the same degree of collapse that mania does. A patient may be obviously changed and still not require hospitalization, lose touch with reality, or become so impaired that normal role functioning falls apart. In practice, hypomania often shows up as a recognizable but not yet catastrophic elevation.

Mania is the more severe state. Once the episode is causing marked impairment, requiring hospitalization, or includes psychotic features, the diagnostic frame changes. That distinction matters because a single manic episode is enough to establish bipolar I disorder, while bipolar II disorder requires hypomania plus major depressive episodes and specifically does not include a full manic episode.

Clinically, one of the most useful questions is not only what symptoms are present, but what those symptoms did. Did the patient stop sleeping and remain fully activated? Did spending, sexual behavior, aggression, or impulsive decisions escalate into serious consequences? Did the person become grandiose, disorganized, or psychotic? Those downstream effects usually clarify the polarity state faster than symptom checklists alone.

Another practical point is that patients often present after the most impairing part of the episode has already passed. Collateral history becomes especially important here. Family, partners, prior records, and timeline reconstruction can help separate a brief period of feeling unusually good from a genuine hypomanic or manic syndrome with diagnostic weight.

The distinction also matters for treatment. Someone who has had mania should generally be treated with the assumption that antidepressant monotherapy can destabilize mood, while someone with suspected bipolar II disorder may still require careful longitudinal review before the diagnosis is treated as settled. In both cases, the history of elevated states changes the risk-benefit calculation for future prescribing.